date,title,source
Oct-18-18,Retrophin to Report Third Quarter 2018 Financial Results,GlobeNewswire
Oct-19-18,"New Research: Key Drivers of Growth for Teva Pharmaceutical Industries, Axovant Sciences, SolarEdge Technologies, NantHealth, Kosmos Energy, and Retrophin  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Oct-25-18,Retrophin Announces Publication of Phase 2 DUET Study of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis in the Journal of the American Society of Nephrology,GlobeNewswire
